◆ 会议时间:2025年5月4-8日
◆ 会议地点:美国 盐湖城
◆ 会议简介:
2025年视觉与眼科研究协会(ARVO)年会将于2025年5月4日至8日在美国盐湖城举行。视觉与眼科研究协会年会(ARVO)是世界上最大的眼科与视觉研究专业会议,预计将有来自全球70多个国家的11,000余名基础和临床研究人员与会,其中约45%的与会者来自美国境外。
视觉与眼科研究协会(ARVO)成立于1928年,是世界上最大和最受尊敬的视觉和眼科研究组织,会员包括来自世界75个国家的近12,000名研究人员。ARVO的使命是在全球范围内宣推进研究,以了解视觉系统,预防、治疗和治愈相关疾病。ARVO鼓励并协助眼科及视觉科学的研究、培训、 出版以及知识共享。未经本站许可禁止复制转载镜像本站任何内容—领域国际医学会议网。
ARVO 2025 - Annual Meeting of the
Association for Research in Vision & Ophthalmology Annual Meeting
Date:
May 4 - 8, 2025
Location:
Calvin L. Rampton Salt Palace Convention Center
Salt Lake City, Utah, USA
The ARVO Annual Meeting is the premiere gathering for eye and vision scientists from across the globe, at all career stages, students, and those in affiliated fields to share the latest research findings and collaborate on innovative solutions. For 2025, the Meeting will be hosted May 4 - 8 in Salt Lake City, Utah.
摘要征文投稿:
The abstract submission perod for the 2025 Annual Meeting will be open from Oct. 8 - Dec. 6, 2024.
Key dates for 2025 abstracts
Jan. 14 |
Abstract review notification sent to First Authors |
Feb. 13 |
Abstract scheduling notification sent to First Authors |
Early March |
Abstract/presentation listing available via online planner |
ARVO membership for 2025 is required to submit an abstract. Membership dues are non-refundable and non-transferable, and do not include registration fees for meetings. To submit an abstract for the 2025 Annual Meeting, membership application and payment needed to be received by ARVO:
- by Dec. 2, 2024, if submitting a paper membership application via mail
- by Dec. 6, 2024, if you wish to join/renew your membership online
*Abstracts must be work that has not been submitted for formal publication or to a preprint server before the abstract submission deadline. After the Dec. 6 abstract submission deadline, an author is at liberty to submit their abstract to a journal for formal publication or to a preprint server.
以下为上届会议信息
摘要征文投稿:
Abstracts
Key dates for the 2024 Abstracts and SIGs
Oct. 16 |
Abstract submission opens |
Dec. 8 |
Abstract submission deadline |
Dec. 12 |
Abstract complete notification sent to First Authors |
Jan. 4, 2024 |
Abstract review notification sent to First Authors |
Feb. 1, 2024 |
Abstract scheduling notification sent to First Authors |
Early March 2024 |
Abstract/presentation listing available via online planner |
点此提交摘要>>>Submit Abstract>>>
Reference Tools
To submit an abstract for the 2024 Annual Meeting, membership application and payment needed to be received by ARVO:
- by Dec. 4, 2023, if submitting a paper membership application via mail
- by Dec. 8, 2023, if you wish to join/renew your membership online
*Abstracts must be work that has not been submitted for formal publication or to a preprint server before the abstract submission deadline. After the Dec. 8 abstract submission deadline, an author is at liberty to submit their abstract to a journal for formal publication or to a preprint server.
ARVO 2024 注册费:
2024 Annual Meeting registration
Annual Meeting registration fees |
By March 8
|
By April 26
|
After April 26 |
ARVO Member* |
$370 |
$530 |
$585 |
ARVO Member-in-Training* |
$255 |
$365 |
$385 |
Nonmember |
$655 |
$815 |
$870 |
Nonmember-in-Training |
$395 |
$505 |
$525 |
The early registration deadline is 11:59pm EDT on March 8.
Education Courses
Saturday, May 4| 8am - 5pm PST
The 2024 Education Courses will be held in-person at the Seattle Convention Center - Arch Building. Courses may be added to your registration for the Annual Meeting. Choose between Full-day or Half-day courses:
Full-day course fee |
By March 8 |
By April 26 |
After April 26 |
Member |
$235 |
$290 |
$320 |
Member-in-Training |
$175 |
$200 |
$220 |
Nonmember |
$310 |
$365 |
$395 |
Nonmember-in-Training |
$215 |
$240 |
$260 |
Half-day course fee |
By March 8 |
By April 26 |
After April 26 |
Member |
$140 |
$175 |
$190 |
Member-in-training |
$105 |
$120 |
$130 |
Nonmember |
$185 |
$220 |
$235 |
Nonmember-in-training |
$130 |
$145 |
$155 |
未来的ARVO年会
ARVO2026: May 1 - 5 // Denver, Colo., USA
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|